The Oligostilbene Gnetin H Is a Novel Glycolysis Inhibitor That Regulates Thioredoxin Interacting Protein Expression and Synergizes with OXPHOS Inhibitor in Cancer Cells

Since aerobic glycolysis was first observed in tumors almost a century ago by Otto Warburg, the field of cancer cell metabolism has sparked the interest of scientists around the world as it might offer new avenues of treatment for malignant cells. Our current study claims the discovery of gnetin H (...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Shivendra, De Carlo, Flavia, Ibrahim, Mohamed A., Penfornis, Patrice, Mouton, Alan J., Tripathi, Siddharth K., Agarwal, Ameeta K., Eastham, Linda, Pasco, David S., Balachandran, Premalatha, Claudio, Pier Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178141/
https://www.ncbi.nlm.nih.gov/pubmed/37175448
http://dx.doi.org/10.3390/ijms24097741

Ejemplares similares

Ejemplares similares